Searched for
SERUM INSTITUTE DENGUE
In a medical breakthrough, first phase-3 dengue vaccine trial begins in IndiaIndia started its inaugural phase 3 clinical trial for the DengiAll dengue vaccine, developed by Panacea Biotec. The trial will include 10,...
SII, the world’s largest vaccine maker, sees demand doubling in five yearsSerum Institute of India Pvt. is gearing up to meet the growing demand for life-saving vaccines, with expectations to double sales in the n...
CDSCO panel gives nod for continuation of phase-II clinical trial of SII's dengue vaccineAn expert committee recommended continuation of phase-II clinical trial of Serum Institute of India's vaccine against dengue after successf...
Don't panic, says Karnataka govt as Zika virus detected in Chikkaballapura distThe Karnataka Health Department has issued an advisory in response to the detection of the Zika virus in a mosquito species in Chikkaballap...
UN authorises 2nd malaria vaccine, developed by Oxford University with help from Serum Institute of IndiaResearch suggests it is more than 75% effective and that protection is maintained for at least another year with a booster. Tedros said the...
Indian Immunologicals targets dengue vaccine launch by January 2026Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top execu...
Biocon Biologics, Serum Institute Life Sciences to expand tie-up for R&D, new vaccinesOn Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs3...
Biocon Biologics to offer 15% stake to Serum Institute Life SciencesUnder the alliance, BBL will get committed access to 100 million doses of vaccines annually for 15 years and commercialisation rights of th...
Second dose of COVID-19 vaccination begins in Tamil NaduHealth Secretary J Radhakrishnan, who inspected the administering of the second dose to healthcare workers at the Government Rajiv Gandhi G...
Mutations, unusual symptoms, and other COVID-19 mysteries that remain unsolvedMany patient samples had also yielded false positive in dengue diagnosis tests.
Pune firm plans to ready 20-40 million Covid 19 vaccine shots for launch by Sept-OctPune-based Serum Institute, credited with affordable and innovative therapies like pneumonia and dengue monoclonal vaccines, plans to price...
Malaria eradication top priority for govt: Harsh VardhanThere are a couple of diseases which are on the radar of the health ministry and malaria is one of them, the Union Health Minister said.
Serum Institute to launch Dengue Monoclonal in India in next two yearsScientific details of the vaccines remained unclear. However, the vaccine maker said it will begin registrations for the vaccine soon.
Serum Institute to launch 4 vaccines, enter US, Europe marketsThe company sells its products in 147 countries and is the largest vaccines manufacturer by dosage globally with 1.2 billion doses per annu...
Serum eyes Rs 10,000 crore revenues by 2022, unveils new vaccinesThe company is also developing vaccine and drug for dengue fever. It has commenced first phase of trials in Singapore and hopes to launch v...
Pune firm set to roll out cure for dengueSerum Institute will develop a drug to treat all 4 strains of dengue, and is in the process of applying for a 'speedy approval' to roll-out...
Paper strip test can detect Ebola, dengue in 10 minutesThe new MIT device relies on lateral flow technology, which is used in pregnancy tests and has recently been exploited for diagnosing strep...
Device to detect dengue from saliva in 20 minutesThe device developed by The Institute of Bioengineering and Nanotechnology (IBN) in Singapore is currently undergoing further development.
Serum Institute of India to invest Rs 1,000 crore to set up new facilityThe company will be making vaccines for pneumonia, rotavirus, dengue and many other diseases in the plant, Adar C Poonawalla dded.
How to usher in vaccinnovation in IndiaThe challenge is to build on India's recent successes in vaccine research to reach the global cutting edge in producing vaccines for killer...